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Abstract
Background: Increased baseline heart rate is associated with cardiovascular risk and all-cause mortality in the general
population. We hypothesized that elevated preoperative heart rate increases the risk of myocardial injury after non-cardiac
surgery (MINS).
Methods: We performed a secondary analysis of a prospective international cohort study of patients aged ≥45 yr undergoing
non-cardiac surgery. Preoperative heart ratewas deﬁned as the last measurement before induction of anaesthesia. The sample
was divided into deciles by heart rate. Multivariable logistic regression models were used to determine relationships between
preoperative heart rate and MINS (determined by serum troponin concentration), myocardial infarction (MI), and death within
30 days of surgery. Separatemodelswere used to test the relationship between these outcomes and predeﬁned binary heart rate
thresholds.
Results: Patients with missing outcomes or heart rate data were excluded from respective analyses. Of 15 087 patients, 1197
(7.9%) sustained MINS, 454 of 16 007 patients (2.8%) sustained MI, and 315 of 16 037 patients (2.0%) died. The highest heart rate
decile (>96 beatsmin−1) was independently associatedwithMINS {odds ratio (OR) 1.48 [1.23–1.77]; P<0.01},MI (OR 1.71 [1.34–2.18];
P<0.01), and mortality (OR 3.16 [2.45–4.07]; P<0.01). The lowest decile (<60 beats min−1) was independently associated with
reduced mortality (OR 0.50 [0.29–0.88]; P=0.02), but not MINS or MI. The predeﬁned binary thresholds were also associated with
MINS, but more weakly than the highest heart rate decile.
Conclusions: Preoperative heart rate >96 beatsmin−1 is associatedwithMINS,MI, andmortality after non-cardiac surgery. This
association persists after accounting for potential confounding factors.
Clinical trial registration: NCT00512109.
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Editor’s key points
• Increased baseline heart rate is associated with cardiovas-
cular morbidity and mortality in the general population,
but its impact on perioperative outcomes is unclear.
• Secondary analysis of an internationalmulticentre study of
patients undergoing non-cardiac surgery was performed.
• In this large prospective cohort study, heat rate >96
beats min−1 was associated with increased myocardial in-
jury, myocardial infarction, and mortality.
More than 310 million surgical procedures are carried out world-
wide each year,withmortality rates of up to 4%.1 2 Cardiovascular
complications are a prominent cause of postoperative morbidity
and mortality.3 Recent data suggest that one in 10 surgical pa-
tients experience postoperative myocardial injury attributable to
ischaemia, characterized by a transient increase in the serum
concentration of cardiac troponin, which is strongly associated
with 30 day death.4 5 In contrast to other acute cardiac events,
perioperativemyocardial injury is predominantly asymptomatic,
and in the absence of routine surveillance of troponin concentra-
tions, four out of ﬁve instances are not identiﬁed.4 6 Conventional
teaching suggests that tachycardia is an important causal factor
for myocardial injury, as a result of myocardial oxygen supply–
demand imbalance.7 8 Epidemiological data from the general
population consistently demonstrate that resting heart rate is
associatedwith cardiovascular risk andmortality.9–12 These rela-
tionships appear independent of underlying pathology or cardio-
respiratory ﬁtness.9–13 Consequently, there has been widespread
interest in therapies to control heart rate, both in generalmedical
and perioperative patients.13 14
A number of trials have demonstrated that perioperative treat-
ment with β-blockers, to lower heart rate, reduces the risk of peri-
operative myocardial infarction (MI).14 15 However, the results of
the largest clinical trial demonstrated that β-block increased the
risk of mortality.15 This has led to the suggestion that the optimal
dose of β-blocker varies, and that preoperative heart ratemight be
used to determine the appropriate dosage in individual patients.16
However, this remains controversial, and the association between
preoperative heart rate and postoperative cardiac complications
has been explored in only a small number of studies.17–20 Except
for the POISE Trial, none of these involved the routine measure-
mentof cardiac biomarkers to identifymyocardial injury, andstat-
istical analyses used arbitrary predeﬁned heart rate thresholds.15
18–20 Thus, it remains unclear whether or not there is an increased
relationship between preoperative heart rate and myocardial in-
jury, or if there is a heart rate threshold at which the risk of post-
operative myocardial injury increases.
The aim of this analysis was to assess, in the perioperative
setting, the relationships between heart rate and cardiovascular
outcomes previously described in general medical patients. We
hypothesized that elevated preoperative heart rate is associated
with increased risk ofmyocardial injury,MI, andmortalitywithin
30 days of surgery.
Methods
Study design
This was a predeﬁned secondary analysis of data prospectively
collected in the Vascular Events in Non-cardiac Surgery Patients
Cohort Evaluation (VISION) study, an international prospective
observational cohort study of clinical outcomes after non-cardiac
surgery. The full methods have been published previously.4 5 Re-
search ethics committees or boards approved the study at each
site before patient recruitment commenced. The studywas regis-
tered with ClinicalTrials.gov (NCT00512109).
Patient population
Patients aged 45 yr or older undergoing non-cardiac surgery under
regional or general anaesthesia with an expected overnight hos-
pital stay were eligible for inclusion. Patients gave written in-
formed consent before surgery or, where this was not possible
(e.g. emergency surgery), consent was obtained within 24 h after
surgery. Eight hospitals used a deferred consent process for pa-
tients who could not provide consent and for whom no next of
kinwasavailable.4 5 Patientswere excluded if they refused consent
or if they had been previously enrolled in the study.
Conduct of the study
A detailed data set was collected before and 30 days after surgery
(deﬁnitions of the variables are reported in the Supplementary
ﬁle). Researchers collected data from patients and their medical
notes. Preoperative heart rate was measured as part of routine
care at each site and was deﬁned as the last heart rate measure-
ment recorded before induction of anaesthesia. Blood was
sampled between 6 and 12 h after surgery and on days 1, 2, and
3 after surgery. Serum troponin T (TnT) concentration was mea-
sured using a Roche Diagnostics (Basel, Switzerland) fourth gen-
eration Elecsys™ assay. If TnT was ≥0.04 ng ml−1 (the widely
accepted laboratory reference value at the start of the study), an
ECG was performed. In the absence of dynamic ECG ﬁndings or
clinical features of myocardial ischaemia, clinicians were en-
couraged to obtain an echocardiogram.
Outcome measures
The primary outcome measure was myocardial injury after non-
cardiac surgery (MINS), deﬁned as TnT≥0.03 ngml−1, adjudicated
as attributable to an ischaemic pathology within 30 days after
surgery. Non-ischaemic causes of TnT elevation (e.g. sepsis, pul-
monary embolism) were excluded. This deﬁnition and TnT
threshold was previously deﬁned using VISION data and is the
deﬁnition of MINS recommended by the European Society of
Anaesthesia and European Society of Intensive Care Medicine
joint taskforce on clinical outcomes in perioperative medicine.4
21 Secondary outcome measures were MI and death within 30
days of surgery. Myocardial infarction was deﬁned according to
the third universal deﬁnition (troponin elevation in the presence
of at least one of the following: ischaemic symptoms; new or
presumed new Q waves, ST segment or T wave changes, or left
bundle branch block on the electrocardiogram; or new or pre-
sumed new regional wall motion abnormality on echocardiog-
raphy).21 Patients with a troponin elevation <0.04 ng ml−1 were
not investigated for evidence of ischaemia.
Statistical analysis
We used SPSS version 22 (IBM, New York, NY, USA) for the main
statistical analysis. We ranked the sample according to integer
values of preoperative heart rate and divided the sample into
deciles, using cut-points closest to each 10th percentile, with ap-
proximately equal numbers of patients in each group. As a result
of the distribution of patients, some groups contained more or
fewer patients than average. The groups were compared for dif-
ferences in baseline characteristics. We constructed multivari-
able logistic regression models for heart rate against each
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outcome measure, considering each decile as a categorical
variable. We used deviation contrasts to compare each heart
rate category with the unweighted average effect for the whole
cohort because we did not want to isolate any particular heart
rate decile as a reference category.22 23 We corrected each multi-
variable model for covariates that were previously associated
with MINS, cardiac events (including MI), or mortality in other
perioperative epidemiological research, as follows: age (45–64,
65–75, or >75 yr), current atrial ﬁbrillation, diabetes mellitus,
hypertension, heart failure, coronary artery disease, peripheral
vascular disease, previous stroke or transient ischaemic attack,
estimated glomerular ﬁltration rate (<30, 30–44, 45–60, or >60 ml
min−1), chronic obstructive pulmonary disease, neurosurgery,
major surgery, and urgent or emergency surgery; thesewere con-
sidered as categorical variables in themultivariablemodels.4 5 24 25
Full deﬁnitions are listed in the Supplementary ﬁle. Missing data
were handled by list-wise deletion. The results of multivariable
logistic regression analyses are presented as odds ratios (ORs)
with 95% conﬁdence intervals. Normally distributed data are ex-
pressed as the mean (), and non-normally distributed data are
expressed as themedian (interquartile range). Binary data are ex-
pressed as percentages.
Secondary analyses
Previous studies have investigated heart rate as a risk factor for
cardiac complications using predeﬁned heart rate thresholds.
To allow comparisons between our ﬁndings and previous re-
search, we repeated our analysis using two heart rate thresholds
that were associated with MI or mortality in the general medical
literature (>70 beats min−1) and the perioperative literature (>104
beats min−1).8 26 We dichotomized the sample according to each
heart rate threshold and constructed multivariable logistic re-
gression models for each outcome measure, corrected for the
previous covariates. Heart rate above the threshold was consid-
ered as a categorical variable.
Sensitivity analyses
We repeated the multivariable logistic regression analyses using
a single heart rate decile as the reference category, rather than
the whole cohort. To determine the inﬂuence of preoperative
atrial ﬁbrillation, we excluded all patients with a history of atrial
ﬁbrillation and repeated the logistic regression analyses. Second-
ly, to determine the inﬂuence of emergency surgery, we excluded
all emergency surgery patients and repeated the logistic regres-
sion analyses. It is plausible that an observed relationship be-
tween heart rate and one or more of the outcome measures
could be confounded by the use of medications that inﬂuence
heart rate. The most relevant agents in clinical practice are β-
adrenoceptor antagonists (β-blockers) and the negatively chrono-
tropic calcium channel blockers, diltiazem and verapamil. To de-
termine the inﬂuence of these agents, we conducted a post hoc
analysis by excluding patients who received a β-blocker, a rate-
limiting calcium channel blocker, or both within 24 h before sur-
gery and repeating the primary statistical analysis. To investigate
the possibility of a non-linear relationship between heart rate
and myocardial injury in more detail, we conducted a post hoc
analysis using multivariable fractional polynomial regression.
This technique ﬁts a set of power functions (3, 2, 1, 0.5, 0, −0.5,
−1, and −2, where 0 represents the natural logarithm) to continu-
ous variables within the model.27 28 We used STATA version 14
(StataCorp LP, College Station, TX, USA) to ﬁt the most efﬁcient
polynomial model to our data and then repeated a logistic
regression analysis using the polynomial functions of the inde-
pendent variables.
Results
A total of 16 079 patients were recruited to the VISION study from
12 hospitals in eight countries between August 6, 2007 and Janu-
ary 11, 2011.4 We excluded patients with missing data describing
preoperative heart rate or patient outcomes. Of 15 087 patients,
1197 (7.9%) sustained MINS, 454 of 16 007 patients (2.8%) sus-
tained MI, and 315 of 16 037 patients (2.0%) died, within 30 days
of surgery. Patients who were missing predeﬁned covariates
were excluded frommultivariable analyses (Fig. 1). Baseline char-
acteristics are presented in Table 1. There was a clear increase in
the incidences of the outcome measures for heart rates >96
beatsmin−1. The highest heart rate decilewas associatedwith in-
creased incidences of preoperative atrial ﬁbrillation (P<0.01), dia-
betes mellitus (P<0.01), peripheral vascular disease (P<0.01),
previous stroke or transient ischaemic attack (P<0.01), chronic ob-
structive pulmonary disease (P=0.02), estimated glomerular ﬁl-
tration rate <30 ml min−1 (P<0.01), and estimated glomerular
ﬁltration rate 30–44 ml min−1 (P<0.01).
The results of multivariable logistic regression analyses for
preoperative heart rate deciles as categorical variables against
MINS, MI, and mortality within 30 days of surgery are reported
in Table 2 and Fig. 2. Most of the associations observed on uni-
variate analysis remained signiﬁcant on multivariate analysis.
In particular, heart rates in the highest decile (>96 beats min−1)
were associated with MINS (OR 1.48 [1.23–1.77]; P <0.01), MI (OR
1.71 [1.34–2.18]; P <0.01), and mortality (OR 3.16 [2.45–4.07];
P<0.01). Heart rates in the ninth decile (88–96 beats min−1) were
also associated with mortality (OR 1.46 [1.08–1.97]; P=0.01), but
not with MINS or MI. Heart rates in the eighth decile (83–87
beats min−1) and ﬁfth decile (73–74 beats min−1) were associated
with MINS (OR 1.36 [1.11–1.66]; P<0.01 and OR 0.71 [0.55–0.91];
P=0.01, respectively), but not with MI or mortality. Heart rates in
the lowest decile (<60 beats min−1) were associated with lower
mortality rates than other deciles (OR 0.50 [0.29–0.88]; P=0.02),
but this group was not associated with MINS or MI (Fig. 2). For
comparison, we present the results of univariable logistic regres-
sion analysis of heart rate deciles against the outcomemeasures,
showing unadjusted ORs in Table 3.
Secondary analyses
We repeated the multivariable analysis for two binary heart rate
thresholds. Heart rates >104 beats min−1 were associated with
MINS (OR 1.38 [1.21–1.57]; P<0.01), MI (OR 1.35 [1.14–1.61];
P<0.01), and mortality (OR 1.89 [1.60–2.24]; P<0.01), as shown in
Table 4. Heart rates >70 beats min−1 were associated with MINS
(OR 1.09 [1.01–1.17]; P=0.02) and mortality (OR 1.52 [1.30–1.77];
P<0.01), but not MI (Table 5).
Sensitivity analyses
Our principal ﬁndings remained similar when we repeated the re-
gression analyses using a single decile (60–64 beats min−1) as the
reference category (Supplementary data, Table S1), except that
heart rates in the lowest decile were no longer associated with
postoperative mortality (OR 0.71 [0.33–1.54]; P=0.39), heart rates
72–74 beats min−1 were no longer associated with myocardial in-
jury (OR 0.83 [0.58–1.17]; P=0.28), and heart rates 69–71 beatsmin−1
were associated with MI (OR 1.68 [1.03–2.73]; P=0.04). To examine
the potential confounding effect of preoperative tachyarrhythmia,
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we repeated the regression analyses excluding patients with cur-
rent atrial ﬁbrillation, themost commonpreoperative arrhythmia.
Whenweexcludedpatientswith current atrialﬁbrillationoremer-
gency surgery, the results were very similar to the main results
(Supplementary data, Tables S2–7).
The association between the highest decile of heart rate and
each of the three outcome measures was not affected by exclu-
sion of patients who received a β-blocker, a rate-limiting calcium
channel blocker, or both within 24 h before surgery (Supplemen-
tary data, Table S8). The ORs for MINS, MI, and 30 day mortality
were 1.52 (1.24–1.85; P<0.01), 1.83 (1.38–24.1; P<0.01), and 2.90
(2.19–3.84; P<0.01), respectively. However, heart rates <60
beats min−1 were no longer negatively associated with mortality
(OR 0.61 [0.33–1.12]; P=0.11). The results of the multivariable frac-
tional polynomial regression analysis conﬁrm the linear associ-
ation between heart rate and the probability of myocardial
injury. The best-ﬁtting model included one heart rate function
that underwent a single linear transformation (Supplementary
data, Table S9). A summary plot of this model is shown in
Fig. 3, which illustrates that as heart rate increases, the probabil-
ity of myocardial injury with 30 days of surgery is increased.
Discussion
The principal ﬁnding of this study is that elevated preoperative
heart rate is associated with increased incidences of MINS, MI,
and death within 30 days of surgery. When we examined the en-
tire range of heart rates, the highest decile (>96 beats min−1) was
consistently associated with higher incidences of each of these
outcomes. Heart rates in the ﬁrst decile (<60 beatsmin−1) were as-
sociated with a lower incidence of mortality, but not MINS or MI.
We found similar, but weaker, associationswith predeﬁned heart
rate thresholds of >70 and >104 beats min−1, which were identi-
ﬁed from the existing general medical and perioperative litera-
ture. The absence of association between heart rates below the
10th decile and outcomes implies that the signal seen with the
binary thresholds is attributable mainly to higher event rates in
patients with heart rates >96 beatsmin−1. Multivariable fraction-
al polynomial analysis suggests that the relationship between
heart rate and myocardial injury is linear.
Our results contrast with those of population-based studies,
in which incremental increases in resting heart rate are asso-
ciated with higher long-term rates of cardiovascular events
across the whole heart rate spectrum.9–12 If a biological relation-
ship exists between heart rate and clinical outcomes, it may have
different proﬁles in patients undergoing surgery compared with
the general population. Therefore, the results of previous peri-
operative studies using arbitrary predeﬁned heart rate thresholds
may not accurately represent the relationship between heart rate
and clinical outcomes, whereas the ﬁndings of population-based
studies are not generalizable to the perioperative period. Our re-
sults provoke the question of whether heart rate reduction is a
16 079 patients recruited into
study
Excluded 24 patients without resting preoperative heart rate
16 055 patients with resting
preoperative heart rate recorded
Heart rate and outcomes available:
Patients with missing outcome data were excluded from
respective analyses:
Myocardial injury: 968 patients excluded
Myocardial infarction: 48 patients excluded
Mortality: 18 patients excluded
Patients with other missing variables were excluded from
multivariable analyses:
Myocardial injury: 1124 patients excluded
Myocardial infarction: 1171 patients excluded
Mortality: 1171 patients excluded
Myocardial injury: 15 087
Myocardial infarction: 16 007
Mortality: 16 037
Patients included in multivariable
analyses:
Myocardial injury: 13 963
Myocardial infarction: 14 836
Mortality: 14 866
Fig 1 Patient ﬂow diagram showing the number of patients included and excluded from each analysis.
Preoperative heart rate and myocardial injury after non-cardiac surgery | 175
 at Queen M
ary, University of London on July 21, 2016
http://bja.oxfordjournals.org/
Downloaded from 
Table 1 Baseline patient characteristics. Descriptive data are stratiﬁed by preoperative heart rate decile, presented as frequencies with percentages (%) or mean (). Data are rounded to the
nearest whole number
Characteristic Preoperative resting heart rate deciles (beats min−1)
Whole cohort <60 60–64 65–68 69–71 72–74 75–79 80–82 83–87 88–96 >96
Number of patients (n) 16 055 1515 1676 1579 1464 1318 2019 1649 1352 1989 1494
Age [yr; mean ()] 65 (53–77) 66 (5–77) 66 (55–77) 66 (54–78) 64 (52–76) 65 (53–77) 65 (53–77) 65 (53–77) 65 (53–77) 65 (52–78) 65 (52–78)
Sex
Male [n (%)] 7739 (48) 915 (60) 888 (53) 795 (50) 704 (48) 634 (48) 914 (45) 784 (48) 578 (43) 871 (44) 667 (45)
Female [n (%)] 8316 (52) 600 (40) 788 (47) 784 (50) 760 (52) 684 (52) 1105 (55) 865 (52) 774 (57) 1118 (56) 827 (55)
Preoperative heart rate
[beats min−1; mean ()]
77 (15) 54 (5) 62 (2) 67 (1) 70 (1) 73 (1) 77 (1) 81 (1) 85 (1) 91 (3) 107 (11)
Preoperative systolic
arterial pressure [mm
Hg; mean ()]
140 (24) 137 (24) 138 (24) 137 (24) 136 (22) 140 (23) 139 (23) 141 (24) 140 (23) 144 (23) 145 (25)
Preoperative arterial pulse
pressure [mm Hg; mean
()]
61 (19) 62 (20) 62 (20) 61 (20) 59 (19) 61 (19) 60 (19) 61 (19) 60 (19) 62 (19) 61 (20)
Co-morbid disorder [n (%)]
Atrial ﬁbrillation 545 (3) 46 (3) 44 (3) 39 (2) 46 (3) 32 (2) 56 (3) 67 (4) 39 (3) 79 (4) 97 (6)
Diabetes mellitus 3153 (20) 258 (17) 294 (18) 281 (18) 278 (19) 243 (18) 411 (20) 341 (21) 264 (20) 422 (21) 355 (24)
Hypertension 8171 (51) 808 (53) 887 (53) 791 (50) 693 (47) 636 (48) 1031 (51) 848 (51) 686 (51) 1006 (51) 771 (52)
Coronary artery disease 1947 (12) 284 (19) 256 (15) 227 (14) 182 (12) 133 (10) 215 (11) 172 (10) 145 (11) 175 (9) 153 (10)
Peripheral vascular
disease
858 (5) 71 (5) 106 (6) 87 (6) 77 (5) 59 (5) 116 (6) 78 (5) 56 (4) 106 (5) 102 (7)
Previous stroke or
transient ischaemic
attack
1167 (7) 123 (8) 121 (7) 107 (7) 101 (7) 89 (7) 134 (7) 108 (7) 77 (6) 164 (8) 140 (9)
Chronic obstructive
pulmonary disease
1337 (8) 116 (7) 128 (8) 118 (7) 120 (8) 108 (8) 156 (8) 147 (9) 112 (8) 180 (9) 149 (10)
Active cancer 2031 (13) 176 (12) 213 (13) 193 (12) 188 (13) 195 (15) 234 (12) 231 (14) 180 (13) 218 (11) 199 (13)
Preoperative estimated glomerular ﬁltration rate [ml min−1; n (%)]
<30 564 (4) 50 (4) 48 (3) 38 (3) 41 (3) 45 (4) 65 (4) 59 (4) 38 (3) 87 (5) 93 (7)
30–44 831 (5) 81 (6) 81 (5) 76 (5) 71 (5) 55 (4) 111 (6) 72 (5) 64 (5) 114 (6) 104 (7)
45–60 1579 (10) 166 (12) 165 (11) 176 (12) 145 (11) 106 (9) 175 (9) 166 (11) 135 (11) 198 (11) 145 (10)
>60 11 938 (74) 1105 (79) 1267 (81) 1157 (80) 1108 (81) 1020 (83) 1505 (8) 1216 (80) 1014 (81) 1467 (79) 1060 (76)
Surgical procedure category [n (%)]
Elective 13 745 (86) 1377 (91) 1530 (91) 1413 (89) 1304 (89) 1149 (87) 1776 (88) 1409 (85) 1118 (83) 1585 (80) 1084 (73)
Urgent 483 (3) 28 (2) 35 (2) 28 (2) 33 (2) 30 (2) 45 (2) 44 (3) 51 (4) 80 (4) 109 (7)
Emergency 1826 (11) 110 (7) 111 (7) 138 (9) 126 (9) 139 (11) 198 (10) 196 (12) 183 (14) 324 (16) 301 (20)
Major surgery [n (%)] 9576 (60) 868 (57) 946 (56) 905 (57) 817 (56) 798 (61) 1202 (60) 980 (59) 846 (63) 1253 (63) 969 (65)
Outcome measures [n (%)]
Myocardial injury 1197 (8) 103 (7) 105 (7) 100 (7) 100 (7) 70 (6) 131 (7) 117 (8) 119 (9) 169 (9) 177 (13)
Myocardial infarction 454 (3) 35 (2) 34 (2) 39 (3) 43 (3) 25 (2) 53 (3) 45 (3) 39 (3) 55 (3) 84 (6)
Mortality 315 (2) 13 (1) 19 (1) 16 (1) 22 (2) 14 (1) 34 (2) 30 (2) 22 (2) 52 (3) 91 (7)
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Table 2Multivariable logistic regression models for preoperative heart rate deciles. Dependent variables are myocardial injury, myocardial
infarction, and mortality within 30 days of surgery. Preoperative heart rate was stratiﬁed by decile. Each decile was compared with the
unweighted average heart rate for the whole sample
Covariates Myocardial injury Myocardial infarction Mortality
Odds ratio P-value Odds ratio P-value Odds ratio P-value
Age (yr)
45–64 (reference) – – – – – –
65–75 1.08 (0.90–1.30) 0.43 1.16 (0.87–1.55) 0.30 1.64 (1.17–2.30) <0.01
>75 2.08 (1.74–2.48) <0.01 1.90 (1.45–2.49) <0.01 2.41 (1.73–3.35) <0.01
Male sex 1.40 (1.22–1.61) <0.01 1.04 (0.85–1.28) 0.70 1.27 (0.99–1.63) 0.06
History of atrial ﬁbrillation 1.53 (1.18–2.00) <0.01 1.29 (0.90–1.85) 0.17 0.97 (0.60–1.56) 0.89
History of diabetes mellitus 1.39 (1.19–1.61) <0.01 1.21 (0.97–1.52) 0.10 0.98 (0.73–1.32) 0.91
History of hypertension 1.31 (1.12–1.54) <0.01 1.41 (1.10–1.80) 0.01 0.98 (0.75–1.29) 0.89
History of heart failure 1.59 (1.26–1.99) <0.01 1.67 (1.24–2.25) <0.01 1.38 (0.92–2.10) 0.12
History of coronary artery disease 1.48 (1.25–1.76) <0.01 2.23 (91.77–2.81) <0.01 0.96 (0.68–1.34) 0.80
History of peripheral vascular disease 2.17 (1.77–2.65) <0.01 2.11 (1.60–2.78) <0.01 1.75 (1.21–2.53) <0.01
History of stroke or transient ischaemic attack 1.46 (1.20–1.78) <0.01 1.14 (0.85–1.52) 0.37 1.53 (1.10–2.15) 0.01
Preoperative estimated glomerular ﬁltration rate (ml min−1)
<30 10.75 (8.69–13.29) <0.01 3.98 (2.96–5.36) <0.01 2.95 (2.01–4.31) <0.01
30–44 2.51 (2.02–3.19) <0.01 1.69 (1.22–2.34) <0.01 1.58 (1.07–2.36) 0.02
45–60 1.68 (1.39–2.03) <0.01 1.40 (1.04–1.87) 0.02 0.94 (0.63–1.40) 0.77
>60 (reference) – – – – – –
History of chronic obstructive pulmonary disease 1.18 (0.97–1.45) 0.10 1.17 (0.83–1.49) 0.46 1.93 (1.40–2.65) <0.01
Neurosurgery 1.14 (0.87–1.51) 0.34 0.58 (0.35–0.98) 0.04 1.82 (1.71–2.82) 0.01
Urgent or emergency surgery 1.82 (1.54–2.15) <0.01 2.14 (1.70–2.69) <0.01 3.11 (2.41–4.02) <0.01
Major surgery 1.66 (1.42–1.93) <0.01 2.19 (1.71–2.80) <0.01 1.51 (1.13–2.02) 0.01
Preoperative heart rate (beats min−1)
<60 0.92 (0.75–1.14) 0.46 0.89 (0.64–1.23) 0.48 0.50 (0.29–0.88) 0.02
60–64 0.86 (0.69–1.06) 0.15 0.72 (0.51–1.01) 0.06 0.71 (0.45–1.13) 0.15
65–68 0.88 (0.71–1.09) 0.26 0.99 (0.72–1.36) 0.96 0.61 (0.37–1.02) 0.06
69–71 1.01 (0.82–1.26) 0.91 1.21 (0.89–1.64) 0.23 1.07 (0.71–1.63) 0.74
72–74 0.71 (0.55–0.91) 0.01 0.74 (0.50–1.09) 0.13 0.70 (0.42–1.17) 0.18
75–79 0.88 (0.73–1.07) 0.21 1.04 (0.79–1.37) 0.79 1.12 (0.79–1.58) 0.53
80–82 1.01 (0.83–1.24) 0.90 0.97 (0.72–1.32) 0.85 1.11 (0.76–1.62) 0.58
83–87 1.36 (1.11–1.66) <0.01 1.12 (0.82–1.54) 0.47 1.06 (0.70–1.61) 0.78
88–96 1.11 (0.93–1.32) 0.23 0.92 (0.70–1.21) 0.92 1.46 (1.08–1.97) 0.01
>96 1.48 (1.23–1.77) <0.01 1.71 (1.34–2.18) <0.01 3.16 (2.45–4.07) <0.01
Heart rate deciles
>96
88–96
83–87
80–82
75–79
72–74
69–71
65–68
60–64
0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 0.2 0.6 1.0 1.4 1.8 2.2 2.6 3.0 2.4 3.8 4.2
<60
Myocardial injury Myocardial infarction Mortality
Fig 2 Forest plot showing the odds ratios for myocardial injury, myocardial infarction, and mortality by each heart rate (HR) decile (in beats per minute), with 95%
conﬁdence intervals. The odds ratios formyocardial injury are as follows: HR <60, 0.92 (0.76–1.14); HR 60–64, 0.86 (0.69–1.06); HR 65–68, 0.88 (0.71–1.09); HR 69–71, 1.01
(0.82–1.26); HR 72–74, 0.71 (0.55–0.91); HR 75–79, 0.88 (0.73–1.07); HR 80–82, 1.01 (0.83–1.24); HR 83–87, 1.36 (1.11–1.66); HR 88–96, 1.11 (0.93–1.32); andHR >96, 1.48 (1.23–
177). The odds ratios for myocardial infarction are as follows: HR <60, 0.89 (0.64–1.23); HR 60–64, 0.72 (0.51–1.01); HR 65–68, 0.99 (0.72–1.36); HR 69–71, 1.21 (0.89–1.64);
HR 72–74, 0.74 (0.50–1.09); HR 75–79, 1.04 (0.79–1.37); HR 80–82, 0.97 (0.72–1.32); HR 83–87, 1.12 (0.82–1.54); HR 88–96, 0.92 (0.70–1.21); and HR >96, 1.71 (1.34–2.18). The
odds ratios for mortality are as follows: HR <60, 0.50 (0.29–0.88); HR 60–64, 0.71 (0.45–1.13); HR 65–68, 0.61 (0.37–1.02); HR 69–71, 1.07 (0.71–1.63); HR 72–74, 0.70 (0.42–
1.17); HR 75–79, 1.12 (0.79–1.58); HR 80–82, 1.11 (0.76–1.62); HR 83–87, 1.06 (0.70–1.61); HR 88–96, 1.46 (1.08–1.97); and HR >96, 3.16 (2.45–4.07).
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potential therapeutic target to reduce the risk of perioperative
cardiovascular events. Previous randomized controlled trials
found that mortality and stroke risk was increased by β-blocker
therapy.15 In our study, 2727 (17.0%) patients received a β-blocker
or negatively chronotropic calcium channel blocker within 24 h
before surgery. After excluding these patients from the analysis,
the independent association betweenheart rates >96 beatsmin−1
and the outcomes remained. However, the negative association
between heart rates <60 beats min−1 andmortality was no longer
statistically signiﬁcant, suggesting that the observed association
may be confounded by rate-controlling medication. Alternative-
ly, theymight suggest that rate-limitingmedicationwasmerely a
marker of underlying heart disease.
The observed associations between elevated preoperative
heart rateandpostoperative outcomesoffera plausiblemechanism
by which tachycardia could promote cardiac complications.8 29
The majority of perioperative MIs are thought to originate not
from the rupture of atheromatous coronary plaque, as in the
general population, but as the result of protracted myocardial is-
chaemia.7 The imbalance between myocardial oxygen supply
and demand, and subsequent myocardial ischaemia, is pro-
moted by multiple factors, including anaemia, hypertension,
hypotension, and hypoxia.7 However, the most prominent candi-
date mechanism is tachycardia, induced by autonomic imbalance,
postoperative pain, hypovolaemia, or reduction in heart rate-
limiting medications, leading to increased oxygen consumption
Table 3 Univariable (unadjusted) logistic regression models for preoperative heart rate deciles. Dependent variables are myocardial injury,
myocardial infarction, and mortality within 30 days of surgery. Preoperative heart rate was stratiﬁed by decile. Each decile was compared
with the unweighted average heart rate for the whole sample
Heart rate deciles Myocardial injury Myocardial infarction Mortality
Odds ratio P-value Odds ratio P-value Odds ratio P-value
<60 0.92 (0.76–1.11) 0.40 0.85 (0.62–1.17) 0.31 0.52 (0.32–0.87) 0.01
60–64 0.85 (0.70–1.02) 0.08 0.74 (0.54–1.02) 0.07 0.69 (0.45–1.06) 0.09
65–68 0.86 (0.71–1.04) 0.11 0.91 (0.67–1.23) 0.54 0.62 (0.39–0.98) 0.04
69–71 0.94 (0.77–1.14) 0.51 1.09 (0.81–1.45) 0.57 0.92 (0.62–1.38) 0.70
72–74 0.71 (0.57–0.89) <0.01 0.70 (0.48–1.01) 0.05 0.65 (0.40–1.06) 0.09
75–79 0.88 (0.75–1.05) 0.15 0.97 (0.75–1.26) 0.82 1.04 (0.74–1.44) 0.83
80–82 0.98 (0.82–1.17) 0.80 1.01 (0.76–1.34) 0.95 1.12 (0.79–1.59) 0.52
83–87 1.21 (1.01–1.45) 0.04 1.07 (0.79–1.45) 0.66 1.00 (0.67–1.49) 0.99
88–96 1.19 (1.02–1.40) 0.03 1.03 (0.79–1.33) 0.85 1.63 (1.23–2.15) <0.01
>96 1.80 (1.54–2.10) <0.01 2.14 (1.72–2.67) <0.01 3.92 (3.11–4.94) <0.01
Table 4 Preoperative heart rate threshold of 104 beats min−1. Multivariable logistic regression models for myocardial injury, myocardial
infarction, and mortality, all within 30 days of non-cardiac surgery. Preoperative heart rate was stratiﬁed according to a threshold of 104
beats min−1
Covariates Myocardial injury Myocardial infarction Mortality
Odds ratio P-value Odds ratio P-value Odds ratio P-value
Age (yr)
45–64 (reference) – – – – – –
65–75 1.07 (0.89–1.29) 0.47 1.15 (0.87–1.54) 0.32 1.60 (1.14–2.24) <0.01
>75 2.05 (1.72–2.45) <0.01 1.88 (1.44–2.47) <0.01 2.37 (1.70–3.29) <0.01
Male sex 1.38 (1.20–1.58) <0.01 1.02 (0.83–1.26) 0.83 1.21 (0.95–1.55) 0.12
History of atrial ﬁbrillation 1.53 (1.18–2.00) <0.01 1.30 (0.91–1.86) 0.16 0.97 (0.60–1.57) 0.91
History of diabetes mellitus 1.40 (1.20–1.63) <0.01 1.22 (0.98–1.53) 0.08 1.01 (0.75–1.35) 0.97
History of hypertension 1.32 (1.13–1.55) <0.01 1.40 (1.09–1.78) <0.01 0.99 (0.75–1.31) 0.95
History of heart failure 1.60 (1.27–2.00) <0.01 1.69 (1.26–2.28) <0.01 1.40 (0.92–2.11) 0.11
History of coronary artery disease 1.45 (1.23–1.72) <0.01 2.19 (1.74–2.76) <0.01 0.87 (0.63–1.22) 0.43
History of peripheral vascular disease 2.15 (1.75–2.63) <0.01 2.11 (1.60–2.78) <0.01 1.77 (1.23–2.55) <0.01
History of stroke or transient ischaemic attack 1.45 (1.20–1.77) <0.01 1.14 (0.85–1.51) 0.39 1.53 (1.10–2.14) 0.01
Preoperative estimated glomerular ﬁltration rate (ml min−1)
<30 10.69 (8.66–13.21) <0.01 3.96 (2.94–5.32) <0.01 2.97 (2.03–4.35) <0.01
30–45 2.50 (2.01–3.10) <0.01 1.70 (1.23–2.34) <0.01 1.57 (1.06–2.34) 0.03
45–60 1.68 (1.39–2.03) <0.01 1.40 (1.05–1.88) 0.02 0.94 (0.63–1.39) 0.74
>60 (reference) – – – – – –
History of chronic obstructive pulmonary disease 1.21 (0.99–1.47) 0.07 1.13 (0.85–1.51) 0.40 2.04 (1.49–2.80) <0.01
Neurosurgery 1.14 (0.86–1.50) 0.36 0.58 (0.35–0.98) 0.04 1.75 (1.13–2.70) 0.01
Urgent or emergency surgery 1.88 (1.59–2.21) <0.01 2.22 (1.77–2.79) <0.01 3.50 (2.72–4.50) <0.01
Major surgery 1.67 (1.43–1.95) <0.01 2.19 (1.71–2.80) <0.01 1.56 (1.17–2.08) <0.01
Heart rate >104 beats min−1 1.38 (1.21–1.57) <0.01 1.35 (1.14–1.61) <0.01 1.89 (1.60–2.24) <0.01
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and resultant ischaemia.7 8 This is supported by evidence from
animal studies, where tachycardia induces subendocardial myo-
cardial necrosis.29 However, it is possible that tachycardia may
simply be a marker of underlying conditions that contribute to
myocardial injury, including systemic inﬂammation and sympa-
thetic autonomic dysfunction.13 30–32 Given this uncertainty, it is
unclear whether therapeutic control of perioperative heart rate
would inﬂuence clinical outcome.
This study has several limitations. The inﬂuences of pre-
medication and anxiety on heart rate are well established. In an
attempt to standardize heart rate measurement, preoperative
heart ratewas recorded before and as close to induction of anaes-
thesia as possible. The potential confounding inﬂuence of atrial
ﬁbrillation, the commonest population-based tachyarrhythmia,
was assessed both through the adjustment of the multivariable
models and by a sensitivity analysis.33–35 Atrial ﬁbrillation was
present in only 6% of patients in the top decile, and the removal
of these patients had little impact on our ﬁndings, nor did exclu-
sion of patients taking β-blockers or rate-limiting calcium chan-
nel blockers, or patients undergoing emergency surgery.
The strengths of our analyses derive from the multicentre
study design and large patient sample. The sample reﬂects a
wide spectrum of non-cardiac surgery taking place in hospitals
in a number of countries, making the results relevant to the ma-
jority of surgical patients. The routine measurement of TnT al-
lowed us to identify subclinical myocardial injury in addition to
subjective clinical outcomes. We planned the statistical analysis
before taking custody of the data and used multivariable models
to correct for confounding factors. However, like all observational
studies, our resultsmay be susceptible to unmeasured confound-
ing. For example, the highest heart rate decile might include pa-
tients in whom the myocardial injury occurred before surgery,
something we were unable to account for in our analysis.36–38
Norwas the presence of a pacemaker recorded, although it is like-
ly that these patients composed only a small percentage of the
study population.
Conclusion
Elevated preoperative heart rate was associated with MINS, MI,
andmortality within 30 days after surgery. This was primarily at-
tributable to signiﬁcantly higher event rates in patients in the
highest decile of heart rate. Further research is needed to under-
stand the effects of heart rate on postoperativemyocardial injury
Table 5 Preoperative heart rate threshold of 70 beats min−1. Multivariable logistic regression models for myocardial injury, myocardial
infarction, andmortality, all within 30 days of non-cardiac surgery. Preoperative heart ratewas stratiﬁed according to a threshold of 70 beats
min−1
Covariates Myocardial injury Myocardial infarction Mortality
Odds ratio P-value Odds ratio P-value Odds ratio P-value
Age (yr)
45–64 (reference) – – – – – –
65–75 1.07 (0.89–1.28) 0.49 1.15 (0.86–1.53) 0.35 1.58 (1.13–2.20) <0.01
>75 2.03 (1.70–2.42) <0.01 1.85 (1.41–2.42) <0.01 2.27 (1.63–3.15) <0.01
Male sex 1.38 (1.20–1.59) <0.01 1.03 (0.84–1.26) 0.81 1.26 (0.98–1.61) 0.07
History of atrial ﬁbrillation 1.61 (1.24–2.09) <0.01 1.37 (0.96–1.95) 0.09 1.08 (0.67–1.74) 0.74
History of diabetes mellitus 1.39 (1.20–1.62) <0.01 1.22 (0.98–1.53) 0.08 0.99 (0.74–1.33) 0.96
History of hypertension 1.31 (1.12–1.53) <0.01 1.38 (1.08–1.77) 0.01 0.97 (0.74–1.28) 0.84
History of heart failure 1.58 (1.26–1.99) <0.01 1.67 (1.24–2.25) <0.01 1.37 (0.91–2.07) 0.14
History of coronary artery disease 1.47 (1.24–1.74) <0.01 2.20 (1.74–2.77) <0.01 0.94 (0.67–1.31) 0.70
History of peripheral vascular disease 2.15 (1.76–2.63) <0.01 2.11 (1.60–2.79) <0.01 1.78 (1.24–2.57) <0.01
History of stroke or transient ischaemic attack 1.47 (1.21–1.78) <0.01 1.14 (0.85–1.52) 0.38 1.55 (1.11–2.16) 0.01
Preoperative estimated glomerular ﬁltration rate (ml min−1)
<30 10.83 (8.77–13.39) <0.01 4.06 (3.02–5.46) <0.01 3.17 (2.17–4.62) <0.01
30–45 2.54 (2.05–3.15) <0.01 1.75 (1.27–2.41) <0.01 1.72 (1.16–2.54) <0.01
45–60 1.69 (1.40–2.05) <0.01 1.41 (1.05–1.89) 0.02 0.97 (0.65–1.44) 0.87
>60 (reference) – – – – – –
History of chronic obstructive pulmonary disease 1.20 (0.98–1.46) 0.08 1.13 (0.84–1.51) 0.42 1.95 (1.42–2.67) <0.01
Neurosurgery 1.14 (0.86–1.50) 0.36 0.58 (0.34–0.98) 0.04 1.79 (1.16–2.76) <0.01
Urgent or emergency surgery 1.91 (1.62–2.25) <0.01 2.30 (1.83–2.89) <0.01 3.53 (2.75–4.54) <0.01
Major surgery 1.66 (1.43–1.94) <0.01 2.19 (1.71–2.81) <0.01 1.55 (1.16–2.07) <0.01
Heart rate >70 beats min−1 1.09 (1.01–1.17) 0.02 1.06 (0.95–1.18) 0.29 1.52 (1.30–1.77) <0.01
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Fig 3 Plot of the fractional polynomial logistic regression model. The x-axis
shows heart rate, and the y-axis is the probability ofmyocardial injury after
non-cardiac surgery (MINS) within 30 days of surgery.
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and to clarify whether or not heart rate reduction in selected pa-
tients can safely reduce major perioperative myocardial ischae-
mic events.
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